Preclinical Medical Device Testing Services Market To Reach $6.7 Billion By 2033

Preclinical Medical Device Testing Services Market Growth & Trends

The global preclinical medical device testing services market size is expected to reach USD 6.7 billion by 2033, registering a CAGR of 8.9%, according to a new report by Grand View Research, Inc. The rising incidence of diseases has provided manufacturers with different approaches for the formation of medical devices and increasing demand for technologically advanced medical devices are the main factors driving the market growth.

The pace of technological advancement in the healthcare industry has vastly increased in recent years. Medical device technology advancements support simple, painless treatment during disease management. Additionally, advancements in medical device technology help with accurate and quick disease diagnosis results, as well as the affordability of technology-based therapeutic tools for disease treatment. Furthermore, numerous governmental agencies and healthcare institutions support medical research facilities. This funding is primarily intended to promote global health care innovations. The growth of medical device testing in the anticipated period is therefore supported by expanding innovation and technological advancement.

Preclinical testing plays a crucial role in the process of creating new products. Before beginning human testing, most of this testing has been completed and reports should be available. According to ISO-10993, biocompatibility testing results are needed to be included in 510(k) notifications for Class II equipment that has immediate patient contact or contact with the blood supply. This shows that the new device's risks are "substantially equivalent" to the predicate device's risks. In order to show the utility of the new device, validate electrical safety, or examine electromagnetic interference, the testing also involves animal and bench studies.

COVID-19 has created an enormous demand for these services. The growth was not significant during the first half, but it became more significant during the second as the industry adopted the new norms at a faster pace amid the pandemic. Numerous projects that were halted because of COVID have been restarted and PPE kits are witnessing an increase in production and testing. During the pandemic, many medical devices in high demand diverted attention from the equipment needed for surgery. The COVID-19 vaccines, ventilators, and pulse oximeters are the main products that witnessed a spike in demand.

 Request a free sample copy or view report summary: Preclinical Medical Device Testing Services Market Report

Preclinical Medical Device Testing Services Market Report Highlights

• The biocompatibility testing services segment dominated the preclinical medical device testing services industry, accounting for the largest share of 57.5% in 2025. This can be attributed to the mandatory regulatory requirements for evaluating the biological safety of medical devices before clinical use.

• The in vivo testing segment dominated the preclinical medical device testing services market, accounting for the largest share of 54.6% in 2025, due to its critical role in evaluating the biological safety, functional performance, and long-term tissue response of medical devices under physiological conditions.

• The class II devices dominated the preclinical medical device testing services industry, accounting for the largest share of 44.3% in 2025, owing to their broad adoption across diagnostic, monitoring, surgical, and therapeutic applications.

• The cardiovascular devices segment dominated the market, with the largest share of 23.9% in 2025, driven by the high prevalence of cardiovascular diseases and ongoing innovation in implantable and interventional technologies.

• The medical device manufacturers segment dominated the preclinical medical device testing services industry, accounting for the largest share of 82.1% in 2025. This can be attributed to increasing product innovation, stringent regulatory approval requirements, and growing outsourcing of specialized testing activities.

• North America dominated the preclinical medical device testing services market with the largest revenue share of 37.4% in 2025. This can be attributed to the growth of the medical device industries in the U.S. and Canada.

Preclinical Medical Device Testing Services Market Segmentation

Grand View Research has segmented the global preclinical medical device testing services market based on service, testing model, device class, application, end use, and region:

Preclinical Medical Device Testing Services Service Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• Biocompatibility Testing Services

  • Material / Chemical Characterization

  • Cytotoxicity Testing

  • Sensitization Testing

  • Irritation & Reactivity Testing

  • Systemic Toxicity Testing

  • Hemocompatibility Testing

  • Implantation Testing

  • Pyrogenicity Testing

  • Others

• Chemistry Testing Services

  • Residuals & Contaminant Analysis

  • Analytical Method Development & Validation

  • Stability & Degradation Studies

  • Other Analytical Chemistry Services

• Microbiology QC Testing Services

  • Sterility Testing & Validation

  • Bioburden Determination

  • Bacterial Endotoxin Testing

  • Others

• Package Validation Services

Preclinical Medical Device Testing Services Testing Model Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• In Vivo Testing

• In Vitro Testing

• Ex Vivo Testing

Preclinical Medical Device Testing Services Device Class Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• Class I

• Class II

• Class III

Preclinical Medical Device Testing Services Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• Cardiovascular Devices

• Orthopedic Devices

• Dental Devices

• Neurological Devices

• Ophthalmic Devices

• General Surgical Devices

• Aesthetic & Cosmetic Devices

• Others

Preclinical Medical Device Testing Services End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• Medical Device Manufacturers

• CRO & CDMO

• Others

Preclinical Medical Device Testing Services Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Oman

  • Qatar

List of Key Players of the Preclinical Medical Device Testing Services Market   

• SGS SA

• Eurofins Scientific

• Pace Analytical Services LLC

• Intertek Group Plc

• WUXI APPTEC

• TÜV SÜD AG

• Sterigenics International LLC (Nelson Labs)

• North American Science Associates, Inc.

• Charles River Laboratories International, Inc.

• Labcorp Drug Development